(R)-2hg Inhibits the BCAT Transaminase in IDH-Mutant Glioma

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2018-162
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Corrigendum: Mutant IDH Inhibits HNF-4α to Block Hepatocyte Differentiation and Promote Biliary Cancer

Nature
Multidisciplinary
2015English

HIF-1α Inhibits IDH-1 Expression in Osteosarcoma

Oncology Reports
MedicineCancer ResearchOncology
2017English

Insulator Dysfunction and Oncogene Activation in IDH Mutant Gliomas

Nature
Multidisciplinary
2015English

Differential Distribution of CCDC26 Glioma-Risk Alleles in Myeloid Malignancies With Mutant IDH1 Compared With Their IDH2R140-mutated or IDH-unmutated Counterparts

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

HNF-4 -Mediated Hepatocyte Differentiation Is Blocked by Mutant IDH

Cancer Discovery
Oncology
2014English

The Engineered Salmonella Typhimurium Inhibits Tumorigenesis in Advanced Glioma

OncoTargets and Therapy
OncologyPharmacology
2015English

Mutant IDH1 and Seizures in Patients With Glioma

Neurology
Neurology
2017English

Vemurafenib Has Activity in Patients With BRAFV600-Mutant Glioma

Cancer Discovery
Oncology
2018English

IDH Mutation Analysis in Glioma Patients by CADMA Compared With SNaPshot Assay and Two Immunohistochemical Methods

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy